What happened

The event date for this report is 2026-07-31. Tracy Tomlinson was offered the clinical trial for ovarian cancer at The Christie hospital in Manchester. The account is based on one supplied report and should be read as a record of conditions known at that point, rather than as a statement about later developments. A woman with advanced ovarian cancer has become the first patient in the world to receive a pioneering new therapy.

The available figures and chronology

Tracy Tomlinson was given the drug at The Christie hospital in Manchester as part of a clinical trial evaluating a new type of treatment for several types of cancer. The therapy, known as ZI-MA4-1, was expected to be tested on people with ovarian cancer, lung cancer, sarcomas and head and neck cancer in a trial led by the Christie, and a site at the Royal Marsden in London. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.

The operational context

The 58-year-old, from Chadderton, Oldham, decided almost straight away she was going to go for it, she said, although she admitted it was a "little bit scary" being the first person to have the treatment. Many people in the early stage study - which is primarily focused on safety - have few other options for survival. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.

What remained uncertain

Tomlinson has already beaten the odds in staying alive, having undergone surgery and several rounds of chemotherapy since she was diagnosed in 2020. The new therapy works by combining two powerful methods in fighting cancer. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.

The record at the time

Taken together, the supplied material supports the main development in the headline and the specific details above. It does not establish what happened after 2026-07-31, and no later outcome is inferred here. The report therefore preserves the event-date framing, attributes the account to the available evidence and avoids turning an early figure or stated plan into a settled result. Further official data, technical findings or independent reporting could refine the picture, but those materials were not part of this packet.